Literature DB >> 16208584

Active and passive screening for tuberculosis in Vaud Canton, Switzerland.

Murielle Monney1, Jean-Pierre Zellweger.   

Abstract

AIM: This retrospective study compared the bacteriological and clinical presentation of tuberculosis and the outcome of treatment in immigrants notified for TB after active screening by chest X-ray at the border with other patients detected by passive screening.
DESIGN: Retrospective study of all patients notified for TB in Vaud Canton in 2001 and 2002.
RESULTS: In Vaud Canton 78% of the 179 patients notified for TB were foreign-born. Among 71 asylum seekers actively screened at the border, 49.3% [CI 37.4-61.2] were symptom-free vs 17.6% [CI 10.3-24.9] among 108 passively screened patients. In the passively screened group, the proportion of asymptomatic patients was 15.4% for Swiss patients, 8.6% for foreign workers, and 29.4% for other foreigners. The average duration of symptoms before diagnosis among patients with complaints was 2 months in actively screened foreign-born, compared to 2.5 months in passively screened patients (no significant difference by Wilcoxon-Mann-Whitney test). The proportion of pulmonary TB cases with positive smear or culture was 63.4% in actively screened patients vs 70.4% in passively detected cases. Among actively screened patients with bacteriological confirmation, 42.2% [CI 27.2-57.2] were asymptomatic compared to 13% [CI 5.31-20.7] for passively screened patients. Considering only smear positive patients, the proportion of symptom-free patients was 22.2% [CI 9.6-34.8] in 45 actively screened cases vs 11.7% [4.4-19.0] for 77 passive screening. Cure and treatment completion rate for new cases reached 88% for foreign workers, 83% for asylum seekers, 85% for Swiss patients, and 78% for other foreigners.
CONCLUSIONS: Actively screened patients were more frequently asymptomatic than passively detected cases, even when considering only patients with bacteriological confirmation. The active screening by chest X-ray of an immigrant population with a high prevalence of tuberculosis allows the early detection and treatment of tuberculosis. This may contribute to the protection of the resident population from infection. The outcome of treatment for tuberculosis was satisfactory in all population groups.

Entities:  

Mesh:

Year:  2005        PMID: 16208584     DOI: 2005/31/smw-10933

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  4 in total

1.  Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding.

Authors:  S den Boon; S Verver; C J Lombard; E D Bateman; E M Irusen; D A Enarson; M W Borgdorff; N Beyers
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

2.  Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome.

Authors:  Monica Sañé Schepisi; Gina Gualano; Claudia Fellus; Nazario Bevilacqua; Marco Vecchi; Pierluca Piselli; Giuliana Battagin; Giulia Silvestrini; Andrea Attanasio; Alberto Vela; Giorgia Rocca; Alessandro Rinaldi; Pietro Benedetti; Salvatore Geraci; Francesco Nicola Lauria; Enrico Girardi
Journal:  BMC Public Health       Date:  2013-09-22       Impact factor: 3.295

3.  Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy.

Authors:  Monica Sañé Schepisi; Gina Gualano; Pierluca Piselli; Marta Mazza; Donatella D'Angelo; Francesca Fasciani; Alberto Barbieri; Giorgia Rocca; Filippo Gnolfo; Piefranco Olivani; Maurizio Ferrarese; Luigi Ruffo Codecasa; Fabrizio Palmieri; Enrico Girardi
Journal:  Infect Dis Rep       Date:  2016-06-24

4.  Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists.

Authors:  Pranav Rajpurkar; Jeremy Irvin; Robyn L Ball; Kaylie Zhu; Brandon Yang; Hershel Mehta; Tony Duan; Daisy Ding; Aarti Bagul; Curtis P Langlotz; Bhavik N Patel; Kristen W Yeom; Katie Shpanskaya; Francis G Blankenberg; Jayne Seekins; Timothy J Amrhein; David A Mong; Safwan S Halabi; Evan J Zucker; Andrew Y Ng; Matthew P Lungren
Journal:  PLoS Med       Date:  2018-11-20       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.